Kidney and urologic disease status update: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 759: Line 759:
| style="padding: 5px 5px; background: #F5F5F5;" |Polycystic kidney disease
| style="padding: 5px 5px; background: #F5F5F5;" |Polycystic kidney disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Khurram
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Nephritic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Nephritic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Nephrotic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Nephrotic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sadaf
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Post-streptococcal glomerulonephritis
| style="padding: 5px 5px; background: #F5F5F5;" |Post-streptococcal glomerulonephritis
Line 791: Line 791:
| style="padding: 5px 5px; background: #F5F5F5;" |Renal cell carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |Renal cell carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Renal osteodystrophy
| style="padding: 5px 5px; background: #F5F5F5;" |Renal osteodystrophy
Line 815: Line 815:
| style="padding: 5px 5px; background: #F5F5F5;" |Renal vein thrombosis
| style="padding: 5px 5px; background: #F5F5F5;" |Renal vein thrombosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehdi
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Wilms' tumor
| style="padding: 5px 5px; background: #F5F5F5;" |Wilms' tumor

Revision as of 14:46, 8 July 2020

System leader: Maneesha Nandimandalam, MD

Progress
Completed 33
In progress 1
Remaining 30

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases
  • Abderhalden-Kaufmann-Lignac syndrome
  • Analgesic nephropathy
 Assigned Shakiba Elsaiey, Ahmed
  • Balkan nephropathy
  • Continuous veno-venous hemofiltration
  • Contrast-induced acute kidney injury
  • Dent's disease
  • Dialysis (LP)
  • Diuresis
  • Fibrillary immunotactoid glomerulopathy
  • Glomerulosclerosis
  • Hypophosphatemia
  • Haff disease
  • Hemodialysis (SP)
  • HIV associated nephropathy
 Assigned Shakiba Elsaiey,Ahmed Completed
  • Hypertensive nephropathy
 Assigned Nasrin Elsaiey,Ahmed
  • Kidney transplantation
  • Milk-alkali syndrome
  • Multicystic dysplastic kidney
  • Nephroptosis
  • Nutcracker syndrome
  • Papillorenal syndrome
  • Peritoneal dialysis (SP)
  • Phosphate nephropathy
 Assingned Ayesha FJ Sogand
  • Pyonephrosis
  • Rhabdomyolysis
 Assingned Ayesha FJ, Sogand
  • Rebound diuresis
  • Renal agenesis
  • Renal artery stenosis
  • Renal papillary necrosis
  • Thin basement membrane disease

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Cardiorenal syndrome Assigned Dina Huda

Completed chapters

Category Chapters Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Electrolyte imbalance (LP) Mehdi Yes Done Mehrian
Hyponatremia Saeedeh Yes Done Mahshid
Hypernatremia Feham Yes Done Elsaiey
Hypokalemia Rc-Aida Yes Done Mahshid
Hyperkalemia Jogeet Yes Done Amandeep
Hypocalcemia Krishna Yes Done Hasan
Hypercalcemia Anmol Yes Done Sudarshana Datta
Glomerular Disease(LP) Mehrian Yes Farima
Lupus Nephritis Aida/ Omer Yes Iqra
Rapidly progressive glomerulonephritis Nazia / Jogeet Yes Aditya
Membranous glomerulonephritis Sunny/ Seyd Amandeep
Membranoproliferative glomerulonephritis rc Arash Aditya
IgA nephropathy Dildar Mehrian
Goodpasture syndrome Akshun Farima
Amyloidosis (LP) Shamila Mehrian
Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type(senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
Hydronephrosis Chandra Aditya
Kidney stone Amandeep Aditya
Polycystic kidney disease Khurram Anmol
Nephritic syndrome Dildar Mehrian
Nephrotic syndrome Mehrian Sadaf
Post-streptococcal glomerulonephritis Manpreet Mehrian
Renal cell carcinoma Farima Anmol
Renal osteodystrophy
Renal tubular acidosis Aditya Sargun
Renal vein thrombosis Saeedeh Mehdi
Wilms' tumor Sargun Farima
Retrieved from "https://www.wikidoc.org/index.php?title=Kidney_and_urologic_disease_status_update&oldid=1622782"